The testing facility at the Al Qarayn Health Centre in Sharjah, the first COVID-19 vaccine trial centre outside Abu Dhabi, received 500 volunteers for the world's first Phase III clinical trials of an inactivated vaccine to combat COVID-19, in the first three days after its opening.
The human trial, which launched in the UAE capital Abu Dhabi in mid-July, is a partnership between Sinopharm's China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42). The visiting delegation praised Bahrain's handling of the virus outbreak and expressed keenness on achieving fruitful results during the third phase of the clinical trials of their coronavirus vaccine in Bahrain. The experiments will be carried out across the capital city of Riyadh, Dammam, and Mecca.
This step comes as a continuation of the studies and research being conducted by the health ministry in this area in cooperation with the World Health Organisation after an advanced multi-centre clinical study was conducted in seven hospitals in the kingdom to combat the disease.
People in Northern Ireland have been urged to consider volunteering for clinical trials for a potential coronavirus vaccine. At least 15,000 volunteers are required for the trial. "I would like everyone to consider signing up to this register so that researchers and the public here can contribute to the global effort to find a vaccine for Covid-19 and help save lives in the future".
The death toll from COVID-19 in Saudi Arabia has reached 3,130 deaths, with the total number of active cases being 287,262.
These were the details of the news Coronavirus: Saudi Arabia and Bahrain to start vaccine trials for this day.
According to an agreement signed between the two countries in April, China is to supply the necessary equipment, materials and expertise to conduct 9 million Covid-19 tests, which involves about $265 million.